16 Chinese pharmaceutical companies listed in 2020 "Global Listed Companies 2000"

[Dynamic Networkpharmaceutical industry] May 13, well-known business magazine Forbes released the 2020 "Global 2000" listThe list is based on a comprehensive selection of corporate sales, profits, assets and market value2020 total revenue of companies on the list is $ 42.3 trillion, gross profit was $ 3.3 trillion, with total assets of $ 201.4 trillion total market capitalization of $ 54.3 trillionChina a total of 367 companies on the list, which in the pharmaceutical industry, a total of 16 Chinese pharmaceutical companies selected, more than twice the number of companies on the list for 19 yearsSpecifically, of the top 16 pharmaceutical companies, including China Sinopharm, Shanghai Pharmaceutical, Hengrui Medicine, Pharmaceutical Resources, Mindray Medical, Yunnan Baiyao, CSPC, Hansen pharmaceutical, biopharmaceutical China, WuXi, intellectual fly biology, bio-medicine Ming, Fosun, Ireland Eye, Kyushu, Guangzhou Baiyunshan pharmaceutical Groupwhere Hansen pharmaceutical, WuXi, intellectual fly biology, Ireland eye medicine for the pharmaceutical companies new to the list this yearIn addition, the highest in this Chinese pharmaceutical companies list the top three for the Sinopharm, Shanghai Pharmaceutical and Hengrui MedicineSinopharm Sinopharm with a turnover of 61.5 billion US dollars, profit of $ 904.4 million, assets of $ 38.7 billion, market capitalization of $ 8.4 billion ranked list 556 bits, compared with 572 in 2019, up 16 ranking, still ranked Chinese pharmaceutical companies list head positiondata show Sinopharm Hong Kong stocks listed companies, affiliated distribution network covering China's 31 provinces, municipalities and autonomous regions, and established a provincial, city, including 251 retail logistics center, covering 14000 hospital two or more hospitals, 120,000 primary health care institutions and nearly 80,000 retail pharmaciesIt can be described as the field of medicine circulation worthy of the "Big Mac."Shanghai Pharmaceutical to Shanghai Pharmaceutical turnover of 27 billion US dollars, profit of $ 592.3 million, assets of $ 19.7 billion, market capitalization of $ 5.0 billion ranking list 1009 bit, compared with 2019 decreased 68, this second ranking Chinese pharmaceutical enterprisesAlso worth mentioning is that, once the last of China Resources Pharmaceutical operating income of HK $ 489.689 billion, net profit of HK $ 4.037 billion, ranking 877 list, ranking China second pharmaceutical enterprisesThe Pharmaceutical Resources fell out of the top three ranked list 1089, ranking fourth Chinese pharmaceutical enterprises, its 2019 revenue was HK $ 204.453 billionShanghai Pharmaceutical Resources medicine beyond the historicalStatistics show that Shanghai Pharmaceutical is a whole industry chain layout of the pharmaceutical companyBy continuing to increase investment in research and innovation, innovation and the introduction of market mechanisms to promote an open, pluralistic model innovation, innovation platform construction at home and abroad, accelerate innovation and external cooperation, innovation and development of Shanghai Pharmaceutical has made great progress Hengrui Medicine Hengrui Medicine with a turnover of 3.4 billion US dollars, profit of $ 782.4 million, assets of $ 4.1 billion, market capitalization of $ 58 billion in ranking list of 1066, compared with 2019 surged 147 The Chinese pharmaceutical enterprises ranked third statistics, Hengrui Medicine, a specialist in medical innovation and high quality drug development, production and marketing of pharmaceutical companies, the innovation in the field of anticancer drugs, surgical treatment, hormone therapy and other drugs are development, Henry innovation agents include imrecoxib, apatinib, sulfur culture filgrastim, pyrrole erlotinib, trastuzumab injection Karui Li and the like.